PetMed Express

Cost Cuts And Digital Upgrades Will Strain Future Margins

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

06 Apr 25

Updated

01 Aug 25

Views

n/a

AnalystConsensusTarget's Fair Value

n/a

-27.6%

22.4%

-27.6%

22.4%

You can edit this narrative until Aug 1 2:40 PM. Then, changes will post as Updates.

Author's Valuation

US$320.0% overvalued

AnalystConsensusTarget Fair Value

Narrative

Updates2

Shared on 01 Aug 25

Fair value Decreased 10%

Consensus revenue growth forecasts for PetMed Express have deteriorated further into negative territory, driving a lower analyst price target from $3.35 to $3.00. What's in the News PetMed Express received a notice from Nasdaq for not timely filing its annual report, with a deadline to submit a compliance plan and potentially regain compliance by late December.

Shared on 01 May 25

AnalystConsensusTarget Fair Value

US$3

20.0% overvalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

-2.05%

Specialty Stores revenue growth rate

0.30%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.43%

Calculation

US$10.05m

Earnings '28

7.55x

PE Ratio '28

US$75.87m

Market Cap '28

US$75.87m

Market Cap '28

20.61m

No. shares '28

US$3.68

Share Price '28

US$3.68 Share Price '28

Discounted to 2025 @ 8.14% p.a.

US$2.91

Fair Value '25